United Therapeutics seeks FDA withdraw of Yutrepia approval
United Therapeutics believes it is entitled to an order instructing the FDA to withdraw the approval of Liquidia's new drug application for Yutrepia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.